Post

Mirodenafil dihydrochloride by AriBio for Depression: Likelihood of Approval

Mirodenafil dihydrochloride is under clinical development by AriBio and currently in Phase I for Depression. According to GlobalData, Phase I …

ABBV-525 by AbbVie for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

ABBV-525 is under clinical development by AbbVie and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData, …

Mivelsiran by Alnylam Pharmaceuticals for Alzheimer’s Disease: Likelihood of Approval

Mivelsiran is under clinical development by Alnylam Pharmaceuticals and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase …

Aflibercept biosimilar by Qilu Pharmaceutical for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval

Aflibercept biosimilar is under clinical development by Qilu Pharmaceutical and currently in Phase III for Wet (Neovascular / Exudative) Macular …

NILK-2301 by LamKap Bio Group for Metastatic Colorectal Cancer: Likelihood of Approval

NILK-2301 is under clinical development by LamKap Bio Group and currently in Phase I for Metastatic Colorectal Cancer. According to …